The document does not detail specific precautions regarding Trabectedin for Injection.

Precautions for Safe Use

Precautions for Trabectedin for Injection are not specified in the description. In general, for chemotherapy agents like Trabectedin, patients should be closely monitored for hematological toxicities, hepatic dysfunction, and renal impairment. Additionally, healthcare providers should assess the patient's cardiovascular status since chemotherapy can increase the risk of arrhythmias and heart failure. The drug is typically contraindicated in patients with significant liver dysfunction due to its hepatic metabolism. Clinical surveillance should include complete blood counts, liver function tests, and regular renal monitoring. Consult the final FDA-approved label for specific precautionary measures post-approval.